Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 3.17 -0.13 (3.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.30 | 52 Week High | $7.27 | |||
| Open | $3.24 | 52 Week Low | $2.39 | |||
| Day High | $3.26 | P/E | N/A | |||
| Day Low | $3.13 | EPS | $-0.61 | |||
| Volume | 837,660 | |||||
